Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives-Reference-Cited by-同舟云学术

Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives

Published:2021-09-07 Issue:20 Volume:64 Page:14913-14929
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shrestha Aarajana¹^ORCID,Kim Nayeon¹,Lee Su-Jeong¹,Jeon Yong Hyun²,Song Ji-Joon³^ORCID,An Hongchan¹^ORCID,Cho Sung Jin⁴,Kadayat Tara Man¹^ORCID,Chin Jungwook¹^ORCID

Affiliation:

1. New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea

2. Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea

3. Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea

4. Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01116

Reference98 articles.

1. Histone methylation: a dynamic mark in health, disease and inheritance

2. Posttranslational Modifications of Histones by Methylation

3. The diverse functions of histone lysine methylation